A mouse model of Escherichia coli .O157: H7 infection for evaluation of antibacterial drugs - In vivo release of verotoxins and toxic effect on mice

Japanese Journal of Chemotherapy

Volumn 46, Issue 3, 1998, Pages 112-118

  Kobayashi, Intetsu ^a   Muraoka, Hiroe ^a   Matsuzaki, Kaoru ^a   Saika, Takeshi ^a   Nishida, Minoru ^a   Akita, Hironobu ^b   Iwata, Satoshi ^c   Sato, Yoshitake ^d   Sunakawa, Keisuke ^e  

^a LSI MEDIENCE CORPORATION   (Japan)

^b ST MARIANNA UNIVERSITY   (Japan)

^c National Hospital Organization Kasumigaura Medical Center   (Japan)

^d Ota Nishinouchi Hospital   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Antibacterial drug; E. coli O157: H7; Germ free mouse; Verotoxin

Indexed keywords

ANTIINFECTIVE AGENT; FOSFOMYCIN; NORFLOXACIN; VEROTOXIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEREMIA; CELL VIABILITY; COLONY FORMING UNIT; DOSE RESPONSE; ESCHERICHIA COLI; GASTROINTESTINAL HEMORRHAGE; MOUSE; NONHUMAN; OCCULT BLOOD; ORAL DRUG ADMINISTRATION; STRAIN DIFFERENCE; TOXICITY TESTING;

EID: 0031921359     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jpn. J. Antibiotics 50: 591-596, 1997
2. Ostroff SM, Kobayashi J M, Lewis J H: Infections with Escherichia coli O157: H7 in Washington state. The first year of statewide disease surveillance. JAMA 262: 355-359, 1989
3. Proulx F, Turgeon J P, Delage G, et al.: Randomized, controlled trial of antibiotic therapy for Escherichia coli O157: H7 enteritis. J Pediatr. 121: 299-303, 1992
4. Walterspiel J N, Ashkenazi S, Morrow A L, et al.: Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin I. Infection 20: 25 -29, 1992
5. Forbes B A, Granato P A: Processing specimens for bacteria. In Manual of Clinical Microbiology 6th ed. (Murray P R, et al. ed.), p.265-281, American Society for Microbiology, Washington D. C., 1995
6. March S B, Ratnam S: Latex agglutination test for detection of Escherichia coli serotype O157. J Clin Microbiol. 27: 1675-1677, 1989
7. Pavia A T, Nichols C R, Green D P, et al.: Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157: H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr. 116: 544-551, 1990
8. Wadolkowski E A, Sung L M, Burris J A, et al.: Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce shiga-like toxin type II. Infect Immun. 58: 3959-3965, 1990
9. Wadolkowski E A, Burris J A, O' Brien A D: Mouse model for colonization and disease caused by enterohemorragic Escherichia coli O157: H7. Infect Immun. 58: 2438-2445, 1990
10. Karpman D, Connell H, Svensson M, et al.: The role of lipopolysaccharide and shiga-like toxin in a mouse model of Escherichia coli O157: H7 infection. JID 175: 611-620, 1997